Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Dag Olav Dahle"'
Autor:
Hege Kampen Pihlstrøm, Mina Susanne Weedon‐Fekjær, Birgitte Leisner Bjerkely, Charlotte von derLippe, Kristin Ørstavik, Per Mathisen, Ketil Heimdal, Trond Geir Jenssen, Dag Olav Dahle, Olga Karin Solberg, Solrun Sigurdardottir
Publikováno v:
JIMD Reports, Vol 62, Iss 1, Pp 56-69 (2021)
Abstract Health‐related quality of life (HRQOL) is reduced in Fabry disease (FD) and associated with clinical disease manifestations, but few have used Fabry‐specific severity scores to study how disease burden interferes with quality of life. We
Externí odkaz:
https://doaj.org/article/f083ac0f662c49bfbb2568975ffba424
Autor:
Solrun Sigurdardottir, Birgitte Bjerkely, Trond G. Jenssen, Per Mathisen, Charlotte von der Lippe, Kristin Ørstavik, Ketil Heimdal, Dag Olav Dahle, Mina Susanne Weedon-Fekjær, Olga Solberg, Hege K. Pihlstrøm
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-11 (2021)
Abstract Background Fabry disease (FD) is an X-linked lysosomal storage disorder characterized by multiorgan dysfunction. Since individuals with FD usually experience progressive clinical disease manifestations, their health-related quality of life (
Externí odkaz:
https://doaj.org/article/6eff872ceb1a471793c5e8897534bfa1
Autor:
Kjersti Benedicte Blom, Kaja Knudsen Bergo, Emil Knut Stenersen Espe, Vigdis Rosseland, Ole Jørgen Grøtta, Geir Mjøen, Anders Åsberg, Stein Bergan, Helga Sanner, Tone Kristin Bergersen, Reidar Bjørnerheim, Morten Skauby, Ingebjørg Seljeflot, Bård Waldum-Grevbo, Dag Olav Dahle, Ivar Sjaastad, Jon Arne Birkeland
Publikováno v:
Blood Pressure, Vol 29, Iss 2, Pp 123-134 (2020)
Purpose: Until recently, it has been believed that donating a kidney not represents any risk for development of cardiovascular disease. However, a recent Norwegian epidemiological study suggests that kidney donors have an increased long-term risk of
Externí odkaz:
https://doaj.org/article/da19597b5aa24d539210ecd5e64cd168
Autor:
Nina Elisabeth Langberg, MD, Trond G. Jenssen, PhD, Anders J. Haugen, PhD, Geir Mjøen, PhD, Kåre I. Birkeland, PhD, Anders Åsberg, PhD, Anders Hartmann, PhD, Dag Olav Dahle, PhD
Publikováno v:
Transplantation Direct, Vol 8, Iss 1, p e1262 (2022)
Background. Endothelial dysfunction is an early and potentially reversible stage in the atherosclerotic process. We assessed endothelial dysfunction noninvasively in kidney transplant recipients (KTRs) and evaluated the association with mortality and
Externí odkaz:
https://doaj.org/article/dc8ae4f1b5a740dbb12428eb811db7b3
Autor:
Hege Kampen Pihlstrøm, Thor Ueland, Annika E Michelsen, Pål Aukrust, Franscesca Gatti, Clara Hammarström, Monika Kasprzycka, Junbai Wang, Guttorm Haraldsen, Geir Mjøen, Dag Olav Dahle, Karsten Midtvedt, Ivar Anders Eide, Anders Hartmann, Hallvard Holdaas
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243759 (2020)
Following a successful renal transplantation circulating markers of inflammation may remain elevated, and systemic inflammation is associated with worse clinical outcome in renal transplant recipients (RTRs). Vitamin D-receptor (VDR) activation is po
Externí odkaz:
https://doaj.org/article/24b38624c4dd4244bfcf20d78ac85d78
Autor:
Birgitte Leisner Bjerkely, Hege Pihlstrøm, Per Mathisen, Kristin Ørstavik, Olga Solberg, Mina Susanne Weedon-Fekjær, Ketil Heimdal, Solrun Sigurdardottir, Charlotte von der Lippe, Trond Jenssen, Dag Olav Dahle
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-11 (2021)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases
Background Fabry disease (FD) is an X-linked lysosomal storage disorder characterized by multiorgan dysfunction. Since individuals with FD usually experience progressive clinical disease manifestations, their health-related quality of life (HRQOL) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82ad019cbe7b5a30760b62944c55282
https://doaj.org/article/6eff872ceb1a471793c5e8897534bfa1
https://doaj.org/article/6eff872ceb1a471793c5e8897534bfa1
Autor:
Charlotte von der Lippe, Trond Jenssen, Hege Pihlstrøm, Olga Solberg, Dag Olav Dahle, Ketil Heimdal, Per Mathisen, Mina Susanne Weedon-Fekjær, Solrun Sigurdardottir, Kristin Ørstavik, Birgitte Leisner Bjerkely
Publikováno v:
JIMD Reports
JIMD Reports, Vol 62, Iss 1, Pp 56-69 (2021)
JIMD Reports, Vol 62, Iss 1, Pp 56-69 (2021)
Health‐related quality of life (HRQOL) is reduced in Fabry disease (FD) and associated with clinical disease manifestations, but few have used Fabry‐specific severity scores to study how disease burden interferes with quality of life. We investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d03b3dfbeb619a1017d511d97a91e088
http://europepmc.org/articles/PMC8574186
http://europepmc.org/articles/PMC8574186
Autor:
Sören Mucha, Andre Franke, Hege Pihlstrøm, Dag Olav Dahle, Geir Mjøen, Espen Melum, Hallvard Holdaas, Bengt Fellström, Alan G. Jardine
Publikováno v:
American Journal of Transplantation. 19:1444-1451
There is a clear genetic contribution to the risk of cardiovascular diseases, and a composite genetic risk score (GRS) based on 27 single nucleotide polymorphisms (SNPs) was reported to predict risk of cardiovascular events in the general population.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede20d2d35fde5633b61e32108efdba7
https://doi.org/10.1111/ajt.15191
https://doi.org/10.1111/ajt.15191
Autor:
Dag Olav Dahle, Geir Mjøen
Publikováno v:
Kidney International Reports
Introduction As many as 50% of U.S. transplant centers do not accept kidney donor candidates with hypertension, citing the link between hypertension, kidney disease, and cardiovascular disease (CVD). Methods We ascertained mortality, CVD, proteinuria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da436d746f63bc9ee37ace75ca344bd
https://pubmed.ncbi.nlm.nih.gov/34013102
https://pubmed.ncbi.nlm.nih.gov/34013102
Autor:
Carl Wilhelm Langberg, Dag Olav Dahle, Karsten Midtvedt, Nicolai Wessel, Knut Brabrand, Morten Skauby
Publikováno v:
Transplantation
Supplemental Digital Content is available in the text.
Kidney transplant recipients (KTRs) are at increased risk of developing renal cell carcinoma (RCC). The cancer can be encountered at different steps in the transplant process. RCC found duri
Kidney transplant recipients (KTRs) are at increased risk of developing renal cell carcinoma (RCC). The cancer can be encountered at different steps in the transplant process. RCC found duri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9a38b682a778a40436761ea999fb677
http://europepmc.org/articles/PMC8667800
http://europepmc.org/articles/PMC8667800